Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

portrait

portrait

Research groups

Infilration of a damaged nerve by Natural Killer cells.

© AJ Davies

Funding

UKRI Future Leaders Fellowship Scheme (2022 - present)

Little Princess Trust - Children’s Cancer and Leukaemia Group (2022 - present)

Human Immune Discovery Initiative - NIHR Oxford Biomedical Research Centre (2020 - 2022)

Funders

UKRI Future Leaders Fellowship Scheme (2022 - present)
Little Princess Trust - Children’s Cancer and Leukaemia Group (2022 - present)

Alexander J. Davies

B.Sc. (Hons), Ph.D.


UKRI Future Leaders Fellow

Biography

Dr Davies’ research focuses on understanding the pathophysiology of nerve injury and neuropathic pain.

He completed his PhD training in neurophysiology with Professor R. Alan North at the University of Manchester. During postdoctoral training at Seoul National University in South Korea his work led to discoveries in spinal mechanisms of neuropathic pain and a clinically-relevant treatment for dental pain. Subsequently, as a NRF Junior Research Fellow, he led a team of international collaborators to reveal a novel immune mechanism of axon degeneration after peripheral nerve injury.

Since moving to the University of Oxford, he has developed methods to study human neuro-immune interactions in vitro, and currently leads several pilot studies phenotyping immune cell function in patients recovering from nerve injury.

Dr Davies was recently awarded a prestigious UKRI Future Leaders Fellowship in which he will investigate the mechanisms of cellular cytotoxicity in immune-mediated recovery from nerve injury. His long-term goals are to translate these biological discoveries into novel immune therapies for neuropathic pain.

Axonal targeting of sensory neurons by NK cells

Cytotoxic neuro-immune 'synapse' between NK cell and mouse DRG neuron results in axon degeneration (NK cells, green; Neuronal calcium signal, magenta).

Collaborators